Latest Conference Articles

Evolocumab offers a 25% reduction in cardiovascular (CV) death, heart attack, or stroke after the first year.

Small case report found an association between the Zika virus and cardiovascular complications.

FOURIER trial meets its primary composite endpoint reducing cardiovascular risk factors.

Some high-risk patients have better than expected outcomes due to frequent follow-up by physicians.

The meeting theme this year, Pain as a Public Health Issue, emphasizes the extent to which pain affects the US population, with more than 100 million Americans suffering from pain.

The study from Sweden found a substantial benefit for men taking the class of drugs that was discovered by accident when researchers were developing a treatment for angina 2 decades ago.

The study finds that this biomarker can show which patients may develop heart disease even if they have no current blockage or elevated cholesterol levels.

Researchers have identified another high associated with marijuana use: the risk of heart failure and cerebrovascular accidents.

Torbjörn Tomson, MD, PhD - professor in neurology, Karolinska Institutet - discusses how health care providers can work with patients to prevent sudden unexpected death in epilepsy (SUDEP).

Recently released studies on Cannabidiol, used to treat certain types of childhood seizures, are showing promising results.

The first feature is Baxter’s Infusion Analytics application, a software solution that provides advanced infusion data analysis and graphical reporting to help identify potential pump programming errors. The second is a suite of Remote Professional Services that offers 24/7 service.

If you want to work as a clinical hospital pharmacist, you better pursue a residency.

Timesaving is key, as pharmacists are routinely being asked to do more with less in the hospital setting.

Third-generation medications for epilepsy are improving treatment options.

The Director of Pharmacy Services at Peninsula Regional Medical Center, chats with Pharmacy Times adding another layer of safety to compound parental nutrition doses.

It’s crucial for pharmacists to be aware of medications associated with high risk for error and harm to patients, and to look for best ways to implement practices for improving safety and patient care.

In this video, Fred Massoomi, PharmD, discusses the importance of educating future pharmacists about the importance sterile compounding.

Ready-to-use products don't involve human contact, giving them an advantage over other options in terms of safety and efficiency

Similar to smartphone updates, cumbersome drug library updates prevent the drug library from being useful to clinicians.

Regardless of some challenges, one health care system, which is comprised of 16 hospitals ranging from large academic settings to rural locations, has seen success with centralized PN compounding.

Health-system pharmacies can regulate cost-effective and efficient operations for parenteral nutrition compounding practices. Laura Mark, MS, PharmD, FASHP, led a tech talk at the Baxter Booth at the ASHP Midyear Clinical Meeting to discuss parenteral nutrition compounding practices.

Mary Choy, of the Touro College of Pharmacy, feted for her efforts to reduce racial and ethnic disparities in health care.

ASHP honors pharmacists whose volunteer work advances the profession.

Jacqueline A. French, MD—professor of neurology, NYU Comprehensive Epilepsy Study Consortium, president, The Epilepsy Study Consortium—discusses what pharmacists should keep in mind when treating patients with epilepsy.

ASHP honored several of their own this week at the Midyear meeting.

Sterile compounding is very important for pharmacies.

Pharmacists are always looking to identify emerging trends that will inevitably have an impact on their practice and patient care.